- Your accurate, authentic and affordable guide to investing
Mid-cap stocks of the week March 05, 2005
The Mid cap stocks listed below are Nifty 500 components - liquid, traded easily and benchmarked volatility. These are stocks that we expect to out-perform the markets. It should be remembered that many of these stocks are trading with abnormally high volumes, maybe operator driven, and have appreciated significantly. Therefore, the risk element is likely to be very high. Take limited exposure to these stocks and maintain stop losses as specified.
|
Individual stocks. |
Apollo Hospitals - this healthcare scrip was recommended vide our earlier editions dtd Nov 21 2004 & Dec 19, 2004 and has appreciated handsomely. Click here to view the previous recommendations. For those interested in the underlying fundamentals, the company has expanded rapidly and announced innovative corporate schemes for bulk executive / labour healthcare contracts for big corporations which will ensure year long occupancy and revenues. The same is reflected in the share price chart which is showing a steady rising tops and bottoms formation. Notice how the scrip invariably bounces higher from it's short & medium term moving averages. Also note how high the relative strength is at 418 ( where 100 = base ). The oscillators are pointing towards a bullishness in the undertone and we recommend a buy on declines on this counter for the patient investor.
Your call of action - Buy on all declines upto 300 levels and leave some room for averaging upto the 275 mark, just in case the scrip falls. Maintain a stop loss at the 250 levels and expect profit taking at the 430+ levels in 2 - 3 quarters time frame in a conducive market.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
Asahi India safety Glass - We had recommended this scrip frequently vide our recent editions dtd Dec 12 2004, Jan 01, 09 and 16 2005. Click here to view the previous recommendations. The scrip was advocated to zoom after the 160 levels were surpassed - a situation which has proved itself. The scrip is in a new trading zone where no previous resistance is likely to be encountered and upmoves are likely to be accelerated. Technical traders will notice how the scrip has a very high relative strength of 749 ( where 100 = base ) and the momentum oscillators are pointing to a firm undertone. We recommend a hold on existing positions and a buy on declines.
Your call of action - fresh entry is recommended even at current levels in small lots and room for averaging be kept upto the 170 levels. A stop loss at the 155 levels is advocated with a profit target of 250 in the short / medium term and 300 + in the long term ( 12 months ) is advocated.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
Fortis Finance - this scrip was recommended vide our sms alert service on Feb 16 2005. The scrip is in a classic bull pattern and making higher tops and bottoms formation. The scrip has been a rank under-performer for years, which explains the poor relative strength of 14 ( where 100 = base ). The stock derives support at it's medium term SMA which is at the 17 levels. We recommend a hold on existing positions and a buy on declines for the patient and discerning investor. Please note - this Ranbaxy group company is listed only on the BSE
Your call of action - Buy at current levels with a room for averaging upto the 17 levels. Maintain a stop loss at the 15 mark and expect to book profits at / above 35 - 40 levels in a years time frame.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
KEC International - this scrip was recommended vide our earlier newsletters dtd Dec 12 2004 and Jan 01 2005. Click here to view the previous recommendations. There has been good appreciation since the previous reco dates and we feel the scrip is due for further upmoves due to the build up in momentum. The chart pattern is suggestive of a rising tops and bottoms and intermittent corrections which will yield above average returns over the next few months. A buy is recommended for the patient and disciplined investor.
Your call of action - Buy on minor declines to the 150 - 155 levels and maintain a stop loss at the 130 levels. Expect to book profits at the 200 + levels in the medium term and 250 + in a years time frame.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
MICO - this scrip was recommended vide our editions dtd Oct 31 2004, Nov 07 & 21 2004, Dec 19 & 26 2004 and Jan 16 2005. Click here to view the previous recommendations. The scrip has not disappointed any bull and if you are a patient investor with an eye for a quiet and strong performance from your stock, this is your scrip. Note the high relative strength of 153 ( where 100 = base ) and the constant higher tops and bottoms formation since Jan 2003. The oscillators have remained in a buy zone and the scrip is at it's lifetime highs. We recommend a buy even at these levels for a patient player.
Your call of action - Buy at current levels and hold with a very liberal stop loss at 1750 and a profit target of 2500 + in a years time on a conservative estimate.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
Shree Cements - this scrip was recommended vide our editions dtd Dec 05, 19 & 26 2004 and Jan 09 & 16 2005. Click here to view the previous recommendations. There has been a steep run upwards since those recos and the scrip has not disappointed any investor. The stock is in a zero resistance zone and is in a strong higher tops and bottoms formation. The relative strength is high at 267 ( where 100 = base ) and the stock rarely falls below it's 13 week SMA. We recommend a hold on existing positions and a buy on declines.
Your call of action - buy on declines to the 325 - 335 levels and hold with a liberal stop loss at the 275 mark. Expect to take profits home at 400 + levels in the medium / long term.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
Tata Sponge - this scrip was recommended as a buy vide our editions dtd Sept 19 & 26 2004 and Oct 03 & 10 2004. Click here to view the previous recommendations. The initial recommendation was to buy near the 165 mark, which has been a fruitful investment. We feel this high relative strength counter ( 209 reading ) has fresh upsides to it and can yield 25 - 30 % profits even from here in the medium / long term easily. The oscillators are suggestive of a bullish undertone and the outlook remains positive for fresh entry.
Your call of action - buy at current levels / on all declines with a stop loss at 165 levels. Expect 275 - 300 levels in a years time frame in a conducive market scenario.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
CNX Mid-cap Index - This midcap benchmark is in a new high and zero resistance zone just like many of the stocks mentioned above. We foresee a support at the 2715 in the short term and a possible target of 3020 in a few weeks time - should the present momentum continue.
Your call of action - since this index is not traded, this is just an academic study.
Apollo Hospitals I Asahi India I Fortis Finance I KEC I MICO I Shree Cements I Tata Sponge I Midcap index I Top I Close window I Print page
- Have a profitable week.
- Vijay L Bhambwani
- Ceo :- Bsplindia.com
The author is a Mumbai based investment consultant and invites feedback at Vijay@BSPLindia.com and ( 022 ) 23438482 / 23400345.
SEBI disclosure :- The author has no positions in any securities mentioned above.
- While all due care has been taken while in compiling the data enclosed herein, we cannot be held responsible for errors, if any, creeping in. Please consult an independent qualified investment advisor before taking investment decisions. This mail is not sent unsolicited, and only advisory in nature. We have accepted no consideration from any company mentioned above and recommend taking decisions on merits of the stocks from our viewpoint. This email is being sent to you as a paid subscriber. Please protect your interests and ours by not disclosing the contents to any un-authorised person/s
Legal notice :- The Professional Ticker Reader is a trademark of Bhambwani Securities (P) Ltd. and any un-authorised replication / duplication in part or full will be infringing our trademark and will result in legal action being enforced on the infringing persons / parties.